Serum tenascin-C is an indicator of inflammatory bowel disease activity

[1]  E. Wisse,et al.  Tenascin expression in human chronic liver disease and in hepatocellular carcinoma. , 2008, Liver.

[2]  W. Kruis.  Cholangitis in ulcerative colitis – a risk factor for colonic malignancy? , 2000, International Journal of Colorectal Disease.

[3]  P. Aitola,et al.  Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma , 2000, International Journal of Colorectal Disease.

[4]  S. Florian,et al.  Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa , 2000, International Journal of Colorectal Disease.

[5]  J. Hugot,et al.  Etiology of the inflammatory bowel diseases , 1999, International Journal of Colorectal Disease.

[6]  A. Schottelius,et al.  A role for transcription factor NF-kB in intestinal inflammation , 1999, International Journal of Colorectal Disease.

[7]  N. Nakao,et al.  Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. , 1998, The American journal of pathology.

[8]  C. Herfarth,et al.  Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel , 1998, Diseases of the colon and rectum.

[9]  C. Haglund,et al.  Enzyme immunoassay for quantification of tenascin in biologic samples. , 1995, Clinical biochemistry.

[10]  G. Vollmer,et al.  Tenascin‐C in serum: A questionable tumor marker , 1995, International journal of cancer.

[11]  A. Faissner,et al.  The tenascin gene family—versatile glycoproteins implicated in neural pattern formation and regeneration , 1995 .

[12]  P. Schlag,et al.  Significance of tenascin serum level as tumor marker in primary colorectal carcinoma , 1995, International journal of cancer.

[13]  K. Kato,et al.  Development and application of an enzyme immunoassay for tenascin. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[14]  J. Yoshida,et al.  DETERMINATION OF TENASCIN IN HUMAN SERUM BY THE USE OF A NEW ENZYME IMMUNOASSAY , 1993 .

[15]  M. Kusakabe,et al.  Expression of tenascin in the developing human small intestine. , 1993, Biochemical and biophysical research communications.

[16]  K. Koretz,et al.  Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. , 1992, Gastroenterology.

[17]  D. Guerry,et al.  Characterization of tenascin secreted by human melanoma cells. , 1991, Cancer research.

[18]  A. Bhattacharyya,et al.  Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. , 1991, Human pathology.

[19]  L. Zardi,et al.  Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues , 1991, International journal of cancer.

[20]  I. Virtanen,et al.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[21]  J. Kruse,et al.  J1/tenascin is a repulsive substrate for central nervous system neurons , 1990, Neuron.

[22]  H. Erickson,et al.  Localization and Quantitation of Hexabrachion (Tenascin) in Skin, Embryonic Brain, Tumors, and Plasma a , 1990, Annals of the New York Academy of Sciences.

[23]  Ami,et al.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.

[24]  P. Ekblom,et al.  Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions [published erratum appears in J Cell Biol 1989 Mar;108(3):following 1175] , 1988, The Journal of cell biology.

[25]  S. Truelove,et al.  Biopsy Studies in Ulcerative Colitis , 1956, British medical journal.

[26]  H. Reimann,et al.  German Measles , 1956 .

[27]  P. Sipponen,et al.  Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach , 2004, Virchows Archiv.

[28]  H. Kosmehl,et al.  Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. , 1994, Pathobiology : journal of immunopathology, molecular and cellular biology.

[29]  I. Virtanen,et al.  Tenascin in inflammatory conditions and neoplasms of the urinary bladder , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[30]  H. Erickson,et al.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. , 1989, Annual review of cell biology.